本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acumen Pharmaceuticals, Inc.

2.02
-0.1200-5.61%
盘后:2.060.0400+1.98%19:59 EDT
成交量:29.16万
成交额:59.76万
市值:1.46亿
市盈率:-1.23
高:2.14
开:2.14
低:2.00
收:2.14
52周最高:3.60
52周最低:1.50
股本:7,221.28万
流通股本:3,704.59万
量比:0.53
换手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):-1.6370
每股收益(LYR):-2.0035
净资产收益率:-120.50%
总资产收益率:-45.77%
市净率:2.55
市盈率(LYR):-1.01

数据加载中...

2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]